Genetics and clinical response to warfarin and edoxaban in patients with venous thromboembolism

Conclusion
In this study, CYP2C9 and VKORC1 genotypes identified patients with VTE at increased bleeding risk with warfarin.

Trial registration number
NCT00986154.

Source: Heart - October 27, 2017 Category: Cardiology Authors: Vandell, A. G., Walker, J., Brown, K. S., Zhang, G., Lin, M., Grosso, M. A., Mercuri, M. F. Tags: Open access Aortic and vascular disease Source Type: research